FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1700-1702 December 3, 1998 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Burlingham, W. J. PubMed Citation

The induction in a host of immunologic tolerance to the major histocompatibility complex (MHC) antigens of a donor (in humans, the HLA antigens) is the unquestioned goal of clinical transplantation. This goal is critical because the strength and diversity of the host's immune responses to the donor's MHC antigens have long been recognized as the principal cause of allograft rejection. Indeed, the MHC system was initially identified by its association with rejection in transplantation studies in animals more than 50 years ago,¹ and it is now recognized for its key role in orchestrating the immune responses to all antigens.

The . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.